Aligos Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $151.5M
Liabilities Breakdown FY2023
Total Liabilities: $59.4M
Asset Breakdown
Total Assets: $151.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $135.7M | 89.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.3M | 2.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $12.6M | 8.3% |
Liabilities Breakdown
Total Liabilities: $59.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.5M | 4.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $56.9M | 95.8% |